Cargando…
Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab
BACKGROUND: To investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly with ranibizumab. METHODS: We retrospectively analyzed the medical records of all patients who received intravitreal ranibizumab (IVR) treatment f...
Autores principales: | Hu, Yuxiang, Cheng, Yi, Xu, Xiaoxuan, Yang, Bo, Mei, Feng, Zhou, Qiong, Yan, Li, Wang, Jun, Wu, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712590/ https://www.ncbi.nlm.nih.gov/pubmed/31455273 http://dx.doi.org/10.1186/s12886-019-1200-4 |
Ejemplares similares
-
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim, Moosang, et al.
Publicado: (2013) -
Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
por: Guan, Jian, et al.
Publicado: (2020) -
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart, Michael W
Publicado: (2013) -
Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020) -
Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)